← SynDRA
GDC-0927
SynDRA canonical compound SYN1973621 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ESR1 | ESR2 |
|---|
| Mechanism of action | estrogen receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- ST9B0EMC0H
- UNII-ST9B0EMC0H
- RG-6047
- RefChem:142770
- GDC-0927 free base
- C28H28FNO4
- orb1709624
- SCHEMBL16325181
- SCHEMBL29357756
- SCHEMBL29640721
- GDC0927
- KJAAPZIFCQQQKX-NDEPHWFRSA-N
- US10227334, Example 3
- BDBM368199
- MFCD31631581
- NSC812902
- AKOS037648960
- AT13024
- NSC-812902
- BG166429
- BS-16112
- DA-73679
- HY-111484
- CS-0042191
- T11380
- GDC-0927 (RG-6047; SRN-927)
- OGJ
- (2S)-2-[4-[2-[3-(fluoromethyl)azetidin-1-yl]ethoxy]phenyl]-3-(3-hydroxyphenyl)-4-methyl-2H-chromen-6-ol
Look up GDC-0927 in the interactive SynDRA portal →